
Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOaEk4TE8yVkNtOXgxOGM0Y0tTaWVZRGFwanVYR0ZUcDZweDVVNW4xNUVwdHBicXRkMk5lUnJTQk52VTZDSmZFemR6b2F6TVZ5LXYyOUVvOWNhU3JGeUoycmZGbXNaLUxYRUZsMDUxUWRoYW5lOU1VSFRmQ1l0VzI5LWl6Z3phUnU1b0VMbk83UHFmczlEWWpNNU52REwzMWVvQ3FjbUZNbF9NTHZnczVzZkI4Qm1LaVVGUnVSUkVWeDJsVVp5dEZiVUN4M0Y?oc=5" target="_blank">Clinical characteristics and outcomes in the adult cystic fibrosis population in Europe from 2014 to 2024: analysis of the European Cystic Fibrosis Society Patient Registry</a>&nbsp;&nbsp;<font color="#6f6f6f">The Lancet</font>
